#BharatBiotech International Ltd has told the #SupremeCourt that #Covaxin has undergone all necessary clinical trials and the Phase 3 efficacy trials revealed the vaccine is 77.8 per cent effective against #COVID19. pic.twitter.com/4yUMduQcrc— IANS (@ians_india) March 22, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


